Key clinical point: Comorbidities and lower socioeconomic status were associated with had less adherence to continuous positive airway pressure therapy.

Major finding: Traumatic brain injury (odds ratio, 1.58; 95% confidence interval, 1.21-2.07), and Medicaid eligibility (OR, 1.48; 95% CI, 1.24-1.75) were independently associated with lower continuous positive airway pressure adherence.

Study details: An analysis of Medicare administrative data involving 3,229 beneficiaries with obstructive sleep apnea who received continuous positive airway pressure therapy between 2009 and 2011.

Disclosures: This study was funded in part by an investigator-initiated grant provided by ResMed to Dr. Wickmire’s institution, the University of Maryland, Baltimore. Dr. Wickmire reported being a scientific consultant to DayZz, Eisai, Merck, and Purdue, and holds shares in WellTap. Dr. Oldstone is a ResMed employee and shareholder. Dr. Sundar reported being a cofounder of Hypnoscure, which creates software for population management of sleep apnea, and an investigator in trials where Resmed and Respironics devices were used. Dr. Ioachimescu reported no relevant financial disclosures.